S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma

References

• ParkinDMGlobal cancer statistics in the year 2000Lancet Oncol20012953354311905707
   PubMed Web of Science ®Google Scholar
• SalgiaRMutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinomaExpert Rev Mol Diagn201616773774927139190
   PubMed Web of Science ®Google Scholar
• GoyaTAsamuraHYoshimuraHPrognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry studyLung Cancer200550222723416061304
   PubMed Web of Science ®Google Scholar
• ArriagadaRBergmanBDunantACisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancerN Engl J Med2004350435136014736927
   PubMed Web of Science ®Google Scholar
• WintonTLivingstonRJohnsonDVinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancerN Engl J Med2005352252589259715972865
   PubMed Web of Science ®Google Scholar
• DouillardJYRosellRDe LenaMAdjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trialLancet Oncol20067971972716945766
   PubMed Web of Science ®Google Scholar
• DonatoRS100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional rolesInt J Biochem Cell Biol200133763766811390274
   PubMed Web of Science ®Google Scholar
• MarenholzIHeizmannCWFritzGS100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)Biochem Biophys Res Commun200432241111112215336958
   PubMed Web of Science ®Google Scholar
• ChenHXuCJinQLiuZS100 protein family in human cancerAm J Cancer Res2014428911524660101
   PubMed Web of Science ®Google Scholar
• SturchlerECoxJADurusselIWeibelMHeizmannCWS100A16, a novel calcium-binding protein of the EF-hand superfamilyJ Biol Chem200628150389053891717030513
   PubMedGoogle Scholar
• MarenholzIHeizmannCWS100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumorsBiochem Biophys Res Commun2004313223724414684152
   PubMed Web of Science ®Google Scholar
• SaitoKKobayashiMNagashioRS100A16 is a prognostic marker for lung adenocarcinomasAsian Pac J Cancer Prev201516167039704426514487
   PubMedGoogle Scholar
• DuBShimJSTargeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancerMolecules2016217 pii:E965
   Web of Science ®Google Scholar
• ZhouWPanHXiaTUp-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancerJ Biomed Sci2014219725287362
   PubMedGoogle Scholar
• TravisWDBrambillaENicholsonAGThe 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 ClassificationJ Thorac Oncol20151091243126026291008
   PubMed Web of Science ®Google Scholar
• GoldstrawPCrowleyJChanskyKThe IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumoursJ Thorac Oncol20072870671417762336
   PubMed Web of Science ®Google Scholar
• KatonoKSatoYJiangSXThe clinicopathological significance of S100A10 expression in lung adenocarcinomasAsian Pac J Cancer Prev201617128929426838226
   PubMedGoogle Scholar
• SungRLeeSHJiMEpithelial-mesenchymal transition-related protein expression in biliary epithelial cells associated with hepatolithiasisJ Gastroenterol Hepatol201429239540223927024
   PubMedGoogle Scholar
• ZhangHLiuJYueDClinical significance of E-cadherin, beta-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinomaJ Clin Pathol2013661193794523853314
   PubMed Web of Science ®Google Scholar
• RyugeSSatoYNagashioRPrognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markersPLoS One201712e017388628358810
   PubMedGoogle Scholar
• XuJYueCFZhouWHAurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosisJ Transl Med20141220025082261
   PubMedGoogle Scholar
• AcharyyaSOskarssonTVanharantaSA CXCL1 paracrine network links cancer chemoresistance and metastasisCell2012150116517822770218
   PubMed Web of Science ®Google Scholar
• van ZijlFKrupitzaGMikulitsWInitial steps of metastasis: cell invasion and endothelial transmigrationMutat Res20117281–2233421605699
   PubMed Web of Science ®Google Scholar
• ZhuWXueYLiangCS100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancerTumour Biol2016379122411225027240591
   PubMedGoogle Scholar
• PapadimitrakopoulouVDevelopment of PI3K/AKT/mTOR pathway inhibitors and their application in personalized therapy for non-small-cell lung cancerJ Thorac Oncol2012781315132622648207
   PubMed Web of Science ®Google Scholar
• ZhangYBaoCMuQReversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cellsNeoplasma201663336237026925782
   PubMed Web of Science ®Google Scholar
• LinYWangZLiuLChenLAkt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cellsLung Cancer201171329129720599289
   PubMed Web of Science ®Google Scholar
• SungWJParkKSKwakSGHyunDSJangJSParkKKEpithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosisInt J Clin Exp Pathol2015888997900926464642
   PubMedGoogle Scholar
• SapkotaDBrulandOParajuliHS100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinomaBMC Cancer20151563126353754
   PubMedGoogle Scholar
• OuWSunHBYeXAdjuvant carboplatin-based chemotherapy in resected stage IIIA-N2 non-small cell lung cancerJ Thorac Oncol2010571033104120502361
   PubMedGoogle Scholar